Silo Pharma, Inc.
SILO
$1.07
$0.04484.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | 0.00% | 0.00% | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | 48.14% | -18.74% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 78.13% | 0.72% | |||
| Operating Income | -79.53% | -0.73% | |||
| Income Before Tax | -86.33% | 0.32% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -86.33% | 0.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -86.33% | 0.32% | |||
| EBIT | -79.53% | -0.73% | |||
| EBITDA | -79.42% | -- | |||
| EPS Basic | -78.51% | 29.26% | |||
| Normalized Basic EPS | -78.58% | 29.19% | |||
| EPS Diluted | -78.51% | 29.26% | |||
| Normalized Diluted EPS | -78.58% | 29.19% | |||
| Average Basic Shares Outstanding | 4.38% | 40.92% | |||
| Average Diluted Shares Outstanding | 4.38% | 40.92% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||